Is Verzenio (abemaciclib) a chemo drug?
- Verzenio is considered a targeted treatment, rather than being a chemo drug, but it may be used to treat certain types of breast cancer.
- Verzenio belongs to the class of medicines known as CDK 4/6 inhibitors which help to reduce the growth and spread of cancer cells in the body.
Verzenio (abemaciclib) is a targeted treatment that helps to reduce the growth and spread of cancer cells in the body. It may be used in combination with endocrine therapy (ET) to treat adults with hormone receptor-positive, HER2-negative (HR+ HER2-), node-positive, early breast cancer at high risk of recurrence, or those with advanced HR+ HER2- advanced or metastatic breast cancer.
How does Verzenio work?
Verzenio belongs to the class of medicines known as CDK4/6 inhibitors.
CDK4/6 inhibitors, such as Verzenio, target particular enzymes, called CDK4 and CDK6. CDK stands for cyclin-dependent kinase, and it is an enzyme that is important for cell division. CDK4/6 inhibitors interrupt signals that stimulate the growth of cancerous cells.
Certain cancers, for example, HR+ HER2- breast cancer, are more likely to have disturbances in CDK4/6, and CDK 4/6 inhibitors may form part of the treatment protocol. Most often, CDK4/6 inhibitors are given at the same time as hormonal therapy (such as an aromatase inhibitor or fulvestrant), although Verzenio may be used alone to treat HR+ HER2- metastatic breast cancer in pre-treated patients.
Research suggests CDK4/6 inhibitors may increase the time people have before cancer spreads. More evidence is needed to determine their impact on overall survival.
Common side effects include fatigue and gastrointestinal disturbances, such as nausea, severe diarrhea, and vomiting. Bone marrow suppression resulting in neutropenia and leukopenia may also occur, although anemia and thrombocytopenia are less common. In general, the side effects associated with CDK4/6 inhibitor therapy are less severe than those experienced with chemotherapy.
Related Questions
References
- Verzenio (abemaciclib) Updated 03/2023. Eli Lilly and Company https://www.drugs.com/pro/verzenio.html
- Verzenio (abemaciclib). 2023. Eli Lilly and Company. https://www.verzenio.com
Read next
Related medical questions
- What is the strongest chemotherapy drug for breast cancer?
- Why are my nipples sore? 7 possible causes
- How long do letrozole side effects last?
- What happens when you stop taking letrozole?
- Does anastrozole cause hair loss?
- How do you relieve joint pain associated with tamoxifen or Aromasin?
- What is the success rate of Keytruda?
- What are monoclonal antibodies?
- What does anastrozole do to your body?
- Is letrozole a form of chemotherapy?
- What is the lifetime or cumulative dose for Adriamycin?
- Does Femara make your hair fall out?
- What is Herceptin? Is Herceptin a chemo drug? How does it work?
- Why give Taxol (Paxel) before carboplatin?
- Does letrozole affect blood sugar levels?
- Will insurance pay for the cost of Ibrance?
- How does AC (Adriamycin and Cytoxan [cyclophosphamide]) work for Breast Cancer?
- What is the success rate for Femara in breast cancer?
- Why do you need to take Xeloda with food?
- Is it common to lose hair AFTER stopping tamoxifen?
- What are the long-term side effects of Adriamycin?
- Which is better - Aromasin or Femara?
- How long can you stay on Herceptin and Perjeta?
- What are 10 key Ibrance side effects to watch out for?
- How long does Herceptin stay in your body?
- How common is hair loss with Ibrance?
- How does Ibrance kill cancer?
- What is Paxel called in the USA?
- Is Ibrance a form of chemo?
- How long can you take Faslodex?
Drug information
Related support groups
- Verzenio (8 questions, 14 members)
- Abemaciclib (6 questions, 5 members)
- Breast Cancer (121 questions, 304 members)